These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29350068)

  • 1. Primary Liver Cancers-Part 1: Histopathology, Differential Diagnoses, and Risk Stratification.
    Jiang K; Al-Diffhala S; Centeno BA
    Cancer Control; 2018; 25(1):1073274817744625. PubMed ID: 29350068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice.
    Desjonqueres E; Campani C; Marra F; Zucman-Rossi J; Nault JC
    Liver Int; 2022 Mar; 42(3):492-506. PubMed ID: 34982503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Liver Cancers, Part 2: Progression Pathways and Carcinogenesis.
    Jiang K; Centeno BA
    Cancer Control; 2018; 25(1):1073274817744658. PubMed ID: 29353494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.
    Wee A
    Cytopathology; 2011 Oct; 22(5):287-305. PubMed ID: 21762411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.
    Umetsu SE; Kakar S
    Surg Pathol Clin; 2023 Sep; 16(3):581-598. PubMed ID: 37536890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic adenoma and focal nodular hyperplasia.
    Shortell CK; Schwartz SI
    Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
    Vogl TJ; Hammerstingl R; Keck H; Felix R
    Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Burkhart RA; Pawlik TM
    Cancer Control; 2017; 24(3):1073274817729235. PubMed ID: 28975828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-7 protein differentiates canine cholangiocarcinoma from hepatocellular carcinoma.
    Jakab C; Kiss A; Schaff Z; Szabó Z; Rusvai M; Gálfi P; Szabára A; Sterczer A; Kulka J
    Histol Histopathol; 2010 Jul; 25(7):857-64. PubMed ID: 20503174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma: Classification, Histopathology and Molecular Carcinogenesis.
    Lendvai G; Szekerczés T; Illyés I; Dóra R; Kontsek E; Gógl A; Kiss A; Werling K; Kovalszky I; Schaff Z; Borka K
    Pathol Oncol Res; 2020 Jan; 26(1):3-15. PubMed ID: 30448973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material.
    Al-Muhannadi N; Ansari N; Brahmi U; Satir AA
    Ann Hepatol; 2011; 10(4):508-15. PubMed ID: 21911893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A practical diagnostic approach to hepatic masses.
    Vyas M; Jain D
    Indian J Pathol Microbiol; 2018; 61(1):2-17. PubMed ID: 29567877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multidisciplinary management of gastrointestinal cancer. The diagnostic and therapeutic approach for primary solid liver tumours in adults.
    Verslype C; Libbrecht L
    Best Pract Res Clin Gastroenterol; 2007; 21(6):983-96. PubMed ID: 18070699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
    Kudo M
    Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.